The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
NU HLDGS LTD ORD SHS CL A G6683N103   15,904,194 1,909,267 SH   SOLE   1,909,267 0 0
ISHARES TR CORE S&P500 ETF 464287200   17,079,094 35,758 SH   SOLE   35,758 0 0
AKERO THERAPEUTICS INC COM 00973Y108   8,699,626 372,575 SH   SOLE   372,575 0 0
89BIO INC COM 282559103   1,413,184 126,516 SH   SOLE   126,516 0 0
MADRIGAL PHARMACEUTICALS INC COM 558868105   17,003,422 73,487 SH   SOLE   73,487 0 0